Effect of Modified Guizhi Fuling Tang(桂枝茯苓汤) on Pulse Pressure and Hematocrit in Elderly Patients with Essential Hypertension with Blood Stasis Syndrome
|更新时间:2021-11-10
|
Effect of Modified Guizhi Fuling Tang(桂枝茯苓汤) on Pulse Pressure and Hematocrit in Elderly Patients with Essential Hypertension with Blood Stasis Syndrome
Journal of Traditional Chinese MedicineVol. 59, Issue 5, Pages: 402-405(2018)
WU Li, CHEN Jihong, GE Danxia, et al. Effect of Modified Guizhi Fuling Tang(桂枝茯苓汤) on Pulse Pressure and Hematocrit in Elderly Patients with Essential Hypertension with Blood Stasis Syndrome[J]. Journal of Traditional Chinese Medicine2018, 59(5): 402-405.
WU Li, CHEN Jihong, GE Danxia, et al. Effect of Modified Guizhi Fuling Tang(桂枝茯苓汤) on Pulse Pressure and Hematocrit in Elderly Patients with Essential Hypertension with Blood Stasis Syndrome[J]. Journal of Traditional Chinese Medicine2018, 59(5): 402-405.DOI: 10.13288/j.11-2166/r.2018.05.011.
Effect of Modified Guizhi Fuling Tang(桂枝茯苓汤) on Pulse Pressure and Hematocrit in Elderly Patients with Essential Hypertension with Blood Stasis Syndrome
Objective To discuss the effect of modified Guizhi Fuling Tang(桂枝茯苓汤
GFT) combined with conventional treatment in senile essential hypertension with blood stasis syndrome. Methods Sixty-eight elderly essential hypertension patients with blood stasis syndrome were randomized into a treatment group and a control group
with 34 cases in each. Both groups were treated with conventional western medicine perindopril tablets and hydrochlorothiazide tablets. Additionally
the treatment group was added with oral modified GFT
one dose a day
for 12 weeks. Before and after treatment
Chinese medicine symptom scores were measured to determine the efficacy of improving Chinese medicine syndromes; ambulatory blood pressure were tested
including 24 h mean systolic blood pressure(24-SBP)
24 h mean diastolic blood pressure(24-DBP)
nighttime mean systolic blood pressure(N-SBP)
nighttime mean diastolic blood pressure(N-DBP)
daytime mean systolic blood pressure(D-SBP) and daytime mean diastolic pressure(D-DBP)
to calculate the pulse pressure; and hematocrit was calculated. Results After treatment in the treatment group
20 cases were markedly effective
12 cases effective
2 cases ineffective
and 0 cases aggravated. The total effective rate was 95. 59%. In the control group
17 cases were markedly effective
10 effective
6 ineffective and 1 case aggravated. The total effective rate was 79. 41%. Effect of improving Chinese medicine syndrome in the treatment group was better than that in the control group(P < 0. 05). The 24-SBP
24-DBP
NSBP
D-SBP and D-DBP in the treatment group after treatment were significantly lower than those before treatment
and also significantly lower than those in the control group after treatment(P < 0. 05 or P < 0. 01). The pulse pressure and hematocrit after treatment were lower than those before treatment in each group
and the decrease in the treatment group was more obvious than that in the control group(P < 0. 05). Conclusion Modified GFT combined with conventional western medicine can reduce the pulse pressure and improve the hematocrit in elderly patients with essential hypertension with blood stasis syndrome
and its curative effect seems superior to that of conventional treatment alone.
Effects of Yangxin Tongmai Formula (养心通脉方) on Methylation Key Genes and the PERK/ATF4/CHOP Signaling Pathway in Myocardial Tissue of Coronary Heart Disease Model Rats with Blood Stasis Syndrome
Construction of a Diagnostic Model for Coronary Heart Disease with Blood Stasis Syndrome Based on Objective Multi-Modal Data Fusion
Effect of Different Time Interventions of Yangxin Tongmai Formula (养心通脉方) on DNA Methylation in Rat Models of Premature Coronary Heart Disease with Blood Stasis Syndrome
Forty Cases of Mid-Stage Diabetes Kidney Disease Patients of Blood Stasis Syndrome Treated with Huayu Tongluo Formula (化瘀通络方) as an Adjunct Therapy: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial
Association between Triglyceride-Glucose Index and Major Adverse Cardiovascular Events Risk in Coronary Heart Disease Patients with Blood Stasis Syndrome after Percutaneous Coronary Intervention
Related Author
ZHANG Chun
ZHANG Shumeng
MAO Yan
CHEN Xing
KUANG Huifang
YANG Yi
CHEN Lingli
LI Jie
Related Institution
Hunan University of Chinese Medicine
Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment of Major Diseases
Experimental Research Center,China Academy of Chinese Medical Sciences
School of Medicine,Hunan University of Chinese Medicine
School of Traditional Chinese Medicine,Hunan University of Chinese Medicine